Another of the acquisitions of companies involved in spectroscopy has been receiving attention from the world’s regulators. Following a ruling by the US Federal Trade Commission sale of the Applied Biosystems mass spectrometry business, jointly owned by Life Technologies and MDS Analytical Technologies, looks to be ready to be concluded. The US FTC have required the sale of MDS’s laser microdissection business to ensure competition in the North American market.
Another stumbling block has been litigation by PerkinElmer against MDS, but this has been settled before it was heard in court. MDS have indicated that they hope the sale to be completed by the end of March.